# Aclaris Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/aclaris-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:38.263568+00:00 | | Last reviewed | 2026-10-16T13:52:38.263568+00:00 | ## Identity - Legal name: Aclaris Therapeutics, Inc. - Display name: Aclaris Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T01:09:19.87744+00:00 | | Completeness | 0.409 | | Record Quality | 0.847 | | Directors | 8 | | Committees | 6 | | Governance events | 20 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anand Mehra, M.D.: Director. Status: current. Independent: true. Since: 2014-01-01. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:5 - Andrew Schiff, M.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:6 - Christopher Molineaux: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:7 - Harold S. Bernstein, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:8 - Maxine Gowen, Ph.D.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:9 - Nathan E. Walker: Director. Status: current. Independent: false. Since: 2012-01-01. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:10 - Vincent Milano: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:11 - William Humphries: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:12 ## Committees - Audit (audit). Chair: Vincent Milano. Members: Vincent Milano (chair, current); Christopher Molineaux (member, current). committee_id=alpha:committee:aclaris-therapeutics-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Vincent Milano (member, current). committee_id=alpha:committee:aclaris-therapeutics-inc:audit-chair - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Christopher Molineaux (member, current). committee_id=alpha:committee:aclaris-therapeutics-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: William Humphries (member, current). committee_id=alpha:committee:aclaris-therapeutics-inc:compensation - Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: William Humphries (member, current). committee_id=alpha:committee:aclaris-therapeutics-inc:compensation-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: Christopher Molineaux. Members: Christopher Molineaux (chair, current); William Humphries (member, current). committee_id=alpha:committee:aclaris-therapeutics-inc:nominating-and-governance ## Executive leadership - Hugh Davis: President, Chief Operating Officer and Director [COO]. Status: current. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:13 - James Loerop: Chief Business Officer. Status: current. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:14 - Jesse Hall: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:15 - Kevin Balthaser: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:16 - Nathan E. Walker: Chief Executive Officer, Chair of the Board of Directors [CEO]. Status: current. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:17 - Roland Kolbeck: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:18 ## Governance events - EXECUTIVE_APPOINTED: Hugh Davis executive of Aclaris Therapeutics, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:f0nnlsnx7hpg - EXECUTIVE_APPOINTED: James Loerop executive of Aclaris Therapeutics, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1gkyexlor8kzj - EXECUTIVE_APPOINTED: Jesse Hall executive of Aclaris Therapeutics, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:u5icib1hadn29 - CFO_CHANGED: Kevin Balthaser executive of Aclaris Therapeutics, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:x27b57hyi6ip - CEO_CHANGED: Nathan E. Walker executive of Aclaris Therapeutics, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:5c49qm1x00exc - EXECUTIVE_APPOINTED: Roland Kolbeck executive of Aclaris Therapeutics, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1exliagwuuwo2 - DIRECTOR_APPOINTED: Harold S. Bernstein, M.D., Ph.D. seat on Aclaris Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1vgxv3ba49gbx - DIRECTOR_APPOINTED: Vincent Milano seat on Aclaris Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:f58dh1xofxt1 - COMMITTEE_CREATED: Audit · Chair committee of Aclaris Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:4jeq6j1bwv25d - COMMITTEE_MEMBER_ADDED: Vincent Milano member of Audit · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:146nhvz8lj5lp - DIRECTOR_APPOINTED: Maxine Gowen, Ph.D. seat on Aclaris Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1dmp0v21e5dvse - DIRECTOR_APPOINTED: Andrew Schiff, M.D. seat on Aclaris Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1pcvem73l4zz3 - DIRECTOR_APPOINTED: William Humphries seat on Aclaris Therapeutics, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1tsd8q91ljx70n - COMMITTEE_CREATED: Compensation; Nominating and Governance committee of Aclaris Therapeutics, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:680mfj10xfvzn - COMMITTEE_MEMBER_ADDED: William Humphries member of Compensation; Nominating and Governance, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:niobhy1pkp9fs - DIRECTOR_APPOINTED: Anand Mehra, M.D. seat on Aclaris Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:8dlcel1hcyid7 - DIRECTOR_APPOINTED: Christopher Molineaux seat on Aclaris Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:dgdc6p1wappsl - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Aclaris Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:zhzah71dm8dah - COMMITTEE_MEMBER_ADDED: Christopher Molineaux member of Audit; Nominating and Governance · Chair, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1knyaxx1qprzt7 - DIRECTOR_APPOINTED: Nathan E. Walker seat on Aclaris Therapeutics, Inc., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:f6izob1qbhiqx ## Scoped resources - `alpha://company/aclaris-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record - `alpha://company/aclaris-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=identity - `alpha://company/aclaris-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/aclaris-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=board - `alpha://company/aclaris-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=committees - `alpha://company/aclaris-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=leadership - `alpha://company/aclaris-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=ownership - `alpha://company/aclaris-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=financials - `alpha://company/aclaris-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/aclaris-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=compensation - `alpha://company/aclaris-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=governance - `alpha://company/aclaris-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/aclaris-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=audit - `alpha://company/aclaris-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=legal - `alpha://company/aclaris-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=risk - `alpha://company/aclaris-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=cyber - `alpha://company/aclaris-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/aclaris-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=agents - `alpha://company/aclaris-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/aclaris-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=events - `alpha://company/aclaris-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=relationships - `alpha://company/aclaris-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=assessments - `alpha://company/aclaris-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:vincent-milano","name":"Vincent Milano"},"source_id":"board_seats"}` - Claim alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:christopher-molineaux","name":"Christopher Molineaux"},"source_id":"board_seats"}` - Claim alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:william-humphries","name":"William Humphries"},"source_id":"board_seats"}` - Claim alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:christopher-molineaux","name":"Christopher Molineaux"},"source_id":"board_seats"}` - Claim alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:william-humphries","name":"William Humphries"},"source_id":"board_seats"}` ## Leadership - Anand Mehra, M.D.: Director. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:5. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - Andrew Schiff, M.D.: Director. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:6. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - Christopher Molineaux: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - Harold S. Bernstein, M.D., Ph.D.: Director. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - Maxine Gowen, Ph.D.: Director. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - Nathan E. Walker: Director. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:10. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - Vincent Milano: Director, Audit · Chair. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:11. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - William Humphries: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:12. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3. - Hugh Davis: President, Chief Operating Officer and Director. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:13. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4555058320f354e4a00bc255a61ca714dcd845f3334b171198e69e98c4bae4d3. - James Loerop: Chief Business Officer. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:14. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a7ed905803120491eb8d894d372354d3d2da7a6ae2841810a7dafd4b2105b4f8. - Jesse Hall: Chief Medical Officer. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:15. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e33bc79ccb694ca222cc457c1fa5c6f75de6e3c880c59dacbcfeee1c44b53c4e. - Kevin Balthaser: Chief Financial Officer. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:16. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:442e28edf8118959a444c83cef90ae87118144dfdf7d189b01a7c281bd0a62b4. - Nathan E. Walker: Chief Executive Officer, Chair of the Board of Directors. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:17. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:72087b4c703635a2e6fe242ab95d219771d49692f1c9f43c913fcba4e65fe045. - Roland Kolbeck: Chief Scientific Officer. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:leadership_role:18. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0c9d5c37fd9adca4afabeb7c9c22e800e8a34cb7b764d76a093ba55067cc5019. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Vincent Milano; Members Vincent Milano (Chair); Christopher Molineaux. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. - Compensation: Chair not stated; Members William Humphries. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. - Nominating and Governance: Chair Christopher Molineaux; Members Christopher Molineaux (Chair); William Humphries. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Aclaris Therapeutics, Inc.. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73c43fe980f8e2260ccde2bbef7f20ab56092049325a3197c488df19d17d024. ## Entity Status - Public listing published. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73c43fe980f8e2260ccde2bbef7f20ab56092049325a3197c488df19d17d024. ## Published Fact - US. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73c43fe980f8e2260ccde2bbef7f20ab56092049325a3197c488df19d17d024. ## Committee Appointment - Vincent Milano: chair, Audit. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. - Christopher Molineaux: member, Audit. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. - William Humphries: member, Compensation. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. - Christopher Molineaux: chair, Nominating and Governance. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. - William Humphries: member, Nominating and Governance. Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca. ## Security Listing - ACRS (NASDAQ). Claim: alpha:claim:company:1f06ef55-5a79-420a-9c34-cc5add2e7eb0:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73c43fe980f8e2260ccde2bbef7f20ab56092049325a3197c488df19d17d024. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:c73c43fe980f8e2260ccde2bbef7f20ab56092049325a3197c488df19d17d024: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/aclaris-therapeutics-inc). - alpha:projection-evidence:document:830db02ecf4c12bf31a294931d65afefdd9f013a3d4bb5d20c177d6ebf8647e3: [Aclaris Therapeutics, Inc. DEF 14A 2026-04-23](https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm). - alpha:projection-evidence:document:4555058320f354e4a00bc255a61ca714dcd845f3334b171198e69e98c4bae4d3: [ACRS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm). - alpha:projection-evidence:document:a7ed905803120491eb8d894d372354d3d2da7a6ae2841810a7dafd4b2105b4f8: [ACRS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm). - alpha:projection-evidence:document:e33bc79ccb694ca222cc457c1fa5c6f75de6e3c880c59dacbcfeee1c44b53c4e: [ACRS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm). - alpha:projection-evidence:document:442e28edf8118959a444c83cef90ae87118144dfdf7d189b01a7c281bd0a62b4: [ACRS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm). - alpha:projection-evidence:document:72087b4c703635a2e6fe242ab95d219771d49692f1c9f43c913fcba4e65fe045: [ACRS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm). - alpha:projection-evidence:document:0c9d5c37fd9adca4afabeb7c9c22e800e8a34cb7b764d76a093ba55067cc5019: [ACRS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm). - alpha:projection-evidence:ce6750810a7bc5df072fb7786be4787412e8a2de5d5daab3e96a1a0569ba1eca: [Audit](https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/aclaris-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/aclaris-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/aclaris-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/aclaris-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T01:09:19.614719+00:00; recorded 2026-10-17T01:09:19.614719+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.